"Radioisotopes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Isotopes that exhibit radioactivity and undergo radioactive decay. (From Grant & Hackh's Chemical Dictionary, 5th ed & McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
| Descriptor ID |
D011868
|
| MeSH Number(s) |
D01.496.749
|
| Concept/Terms |
Radioisotopes- Radioisotopes
- Radioactive Isotopes
- Isotopes, Radioactive
- Radionuclides
Daugter Isotopes- Daugter Isotopes
- Isotopes, Daugter
- Radiogenic Isotopes
- Isotopes, Radiogenic
- Daughter Nuclides
- Nuclides, Daughter
|
Below are MeSH descriptors whose meaning is more general than "Radioisotopes".
Below are MeSH descriptors whose meaning is more specific than "Radioisotopes".
This graph shows the total number of publications written about "Radioisotopes" by people in this website by year, and whether "Radioisotopes" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2011 | 0 | 1 | 1 |
| 2015 | 2 | 1 | 3 |
| 2016 | 1 | 1 | 2 |
| 2017 | 1 | 0 | 1 |
| 2019 | 0 | 2 | 2 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Radioisotopes" by people in Profiles.
-
Targeted radionuclide therapy for gliomas: Emerging clinical trial landscape. Neuro Oncol. 2024 Dec 09; 26(Supplement_9):S208-S214.
-
Real-world safety and effectiveness of radium-223 in patients with metastatic castration-resistant prostate cancer: Interim analyses of the prospective, observational RAPIT study. Int J Cancer. 2024 Oct 01; 155(7):1268-1277.
-
Unlocking Precision in Radioembolization: Navigating the Future of Holmium-166 Radioembolization Mapping and Lung Shunt Study by Implementing Scout Dosimetry. Cardiovasc Intervent Radiol. 2024 Apr; 47(4):451-452.
-
Transformation of G1-G2 neuroendocrine tumors to neuroendocrine carcinomas following peptide receptor radionuclide therapy. Endocr Relat Cancer. 2024 Apr 01; 31(4).
-
Alpha Particle-Emitting Radiopharmaceuticals as Cancer Therapy: Biological Basis, Current Status, and Future Outlook for Therapeutics Discovery. Mol Imaging Biol. 2023 Dec; 25(6):991-1019.
-
Production, isolation, and shipment of clinically relevant quantities of astatine-211: A simple and efficient approach to increasing supply. Nucl Med Biol. 2023 Nov-Dec; 126-127:108387.
-
Dosimetric implications of the potential radionuclidic impurities in 153Sm-DOTMP. Appl Radiat Isot. 2022 Jul; 185:110246.
-
223Ra Induces Transient Functional Bone Marrow Toxicity. J Nucl Med. 2022 10; 63(10):1544-1550.
-
External Validation of a Clinical Score for Patients With Neuroendocrine Tumors Under Consideration for Peptide Receptor Radionuclide Therapy. JAMA Netw Open. 2022 01 04; 5(1):e2144170.
-
Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma. Eur J Cancer. 2022 02; 162:221-236.